BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal
Status: | Recruiting |
---|---|
Conditions: | Ovarian Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/2/2019 |
Start Date: | April 24, 2018 |
End Date: | December 31, 2023 |
Contact: | Elizabeth Schrier |
Email: | Elizabeth_Schrier@DFCI.HARVARD.EDU |
Phone: | 617-582-7396 |
This research study is evaluating a new intervention, BOLSTER, which was designed to provide
more support for patients with ovarian cancer and their caregivers after a hospitalization.
more support for patients with ovarian cancer and their caregivers after a hospitalization.
Hospitalizations can be difficult for patients with cancer, especially when they are
transitioning home. Patients and caregivers are often expected to perform complex medical and
nursing tasks with little or no preparation. Patients and caregivers report high levels of
unmet needs for information about how best to manage symptoms and new medical procedures
(such as managing new tubes, lines or drains).
The study team has developed a research project which aims to address these needs. If a
patient agrees to participate in the study, she will take part in a program called BOLSTER
(Building Out Lifelines for Safety, Trust, Empowerment and Renewal). BOLSTER will provide
patients and caregivers with education and skills training, symptom management, and support
across care settings.
transitioning home. Patients and caregivers are often expected to perform complex medical and
nursing tasks with little or no preparation. Patients and caregivers report high levels of
unmet needs for information about how best to manage symptoms and new medical procedures
(such as managing new tubes, lines or drains).
The study team has developed a research project which aims to address these needs. If a
patient agrees to participate in the study, she will take part in a program called BOLSTER
(Building Out Lifelines for Safety, Trust, Empowerment and Renewal). BOLSTER will provide
patients and caregivers with education and skills training, symptom management, and support
across care settings.
Patient eligibility criteria
- adults (≥18 years old);
- ovarian cancer receiving anti-neoplastic therapy;
- Hospitalized;
- Plan to receive ongoing care at DFCI;
- Willingness to be audio taped for the study (for monitoring of study fidelity).
Patient exclusion criteria
- Unable to read and respond to questions in English;
- Cognitive impairment;
- Unable to complete the baseline interview;
- Plan for immediate hospice referral
Caregiver eligibility criteria
- Adults (≥18 years old);
- Family member or friend of an eligible patient;
- Willingness to be audio taped for the study (for monitoring of study fidelity).
Caregiver exclusion criteria:
- Unable to read and respond to questions in English,
- Cognitive impairment
- Unable to complete the baseline interview
We found this trial at
1
site
450 Brookline Ave
Boston, Massachusetts 2215
Boston, Massachusetts 2215
617-632-3000
Principal Investigator: Alexi A Wright, MD, MPH
Phone: 617-582-7396
Dana-Farber Cancer Institute Since it’s founding in 1947, Dana-Farber has been committed to providing adults...
Click here to add this to my saved trials